BICO Group
18.00 SEK
+1.47 %
Less than 1K followers
BICO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+1.47 %
-0.44 %
+6.51 %
-14.53 %
-11.07 %
-49.21 %
-68.48 %
-95.50 %
+32.11 %
BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
1.27B SEK
Turnover
5.01M SEK
Revenue
1.5B
EBIT %
-86.33 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19/8
2026
Interim report Q2'26
11/11
2026
Interim report Q3'26
17/2
2027
Annual report '26
All
Webcasts
Press releases
ShowingAll content types
Bulletin from the Annual General Meeting in BICO Group AB (publ)
Redeye: BICO (Q1 review): Organic growth at no-growth multiples
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools

